Picture of Deciphera Pharmaceuticals logo

DCPH — Deciphera Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Deciphera Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

* Deciphera Pharmaceuticals Inc  DCPH.OQ  reported a
quarterly
adjusted loss of 54 cents​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -60 cents.  The mean expectation of
eleven analysts for the quarter was for a loss of 58 cents per
share. Wall Street expected results to range from -65 cents
to -50 cents per share.
    * Revenue rose 32.9% to $48.30 million from a year ago;
analysts
expected $45.92 million. 
    * Deciphera Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 54 cents​.
    * The company reported a quarterly loss of $47.19 million.
    * Deciphera Pharmaceuticals Inc shares had fallen by 8.5%
this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 2.6%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Deciphera
Pharmaceuticals Inc is $23.00 
This summary was machine generated from LSEG data February 6 at
01:51 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.58          -0.54          Beat
 Sep. 30 2023      -0.61          -0.58          Beat
 Jun. 30 2023      -0.62          -0.57          Beat
 Mar. 31 2023      -0.59          -0.60          Missed

Recent news on Deciphera Pharmaceuticals

See all news